UNICANCER   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Paris France (1945)

Organization Overview

First Clinical Trial
1994
NCT00002566
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

UNICANCER